Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03975387
Title Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Astex Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Site#114 Duarte California 91010 United States Details
Cedars-Sinai Medical Center Site #105 Los Angeles California 90048 United States Details
Hoag Hospital Site#110 Newport Beach California 92663 United States Details
Holden Comprehensive Cancer Center Site#108 Iowa City Iowa 52242 United States Details
University of Michigan Rogel Cancer Center Site#109 Ann Arbor Michigan 48109 United States Details
Regions Cancer Center Site #115 Saint Paul Minnesota 55101 United States Details
Columbia University Irving Medical Center - Herbert Irving Pavilion Site#104 New York New York 10032 United States Details
University of Pennsylvania-Abramson Cancer Center Site#113 Philadelphia Pennsylvania 19104 United States Details
The University of Texas MD Anderson Cancer Center Site #102 Houston Texas 77030 United States Details
NEXT Oncology Site #101 San Antonio Texas 78229 United States Details
Virgnia Cancer Specialists Site #103 Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field